Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Adrenergic beta-1 receptor genetic variation predicts longitudinal rate of GFR decline in hypertensive nephrosclerosis
Nephrology Dialysis Transplantation, 09/14/09
Fung MM et al. – GFR decline rate in hypertensive renal disease is controlled in part by genetic variation within the adrenergic pathway, particularly at ADRB1. The results suggest novel strategies to approach the role of the adrenergic system in the risk and treatment of progressive renal disease.
Related Articles
Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis
Scandinavian Journal of Rheumatology, 10/02/09
Relevance Score: 91%
Chronic renal insufficiency, cardiovascular disease and mortality in women: a causal relationship or coincidence?
Women's Health, 11/02/09
Relevance Score: 89%
Measured GFR as a Confirmatory Test for Estimated GFR
Journal of the American Society of Nephrology, 10/16/09
Relevance Score: 88%
Renal Function in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial
The Journal of Pediatrics, 11/03/09
Relevance Score: 87%
Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: Relevance of age and dose as risk factors
European Journal of Cancer, 10/23/09
Relevance Score: 87%
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Long-Term Stability of Cardiovascular and Catecholamine Responses to Stress Tests. An 18-Year Follow-Up Study
Hypertension, 12/07/09
Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Convertng Enzyme 2. Prevention of Angiotensin II–Dependent Hypertension
Hypertension, 12/07/09
Non-congenital heart disease associated pediatric pulmonary arterial hypertension
Progress in Pediatric Cardiology, 12/07/09
Sponsor
Article Search
Sponsor


See Latest Articles


